30 search results for: asthma

Pediatric <b>Asthma</b> Trajectory and Clinical Remission
expert video

Pediatric Asthma Trajectory and Clinical Remission

Type 2 Inflammation
Join Dr. Leonard Bacharier as he discusses the definition of clinical remission in pediatric asthma and how it can represent a potential target in pediatric asthma management.
View more
ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe <b>Asthma</b>?
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Pulmonology
Join Drs. Len Bacharier and Sharon Dell as they highlight the natural course of pediatric asthma progression over time.
View more
Mucus Plugging as a Potential Target in <b>Asthma</b> Management
expert video

Mucus Plugging as a Potential Target in Asthma Management

Type 2 Inflammation
Join Dr. Celeste Porsbjerg as she explores the mechanisms underlying mucus plugging development as mucociliary clearance. She explains how type 2 cytokines—particularly IL-13—impair this clearance mechanism, leading to mucus plugging, and worsened asthma outcomes.
View more
Screen depicting a mucus plug in the airways
videoanimation

A view into the Airway: The Pathophysiology and Clinical Relevance of Mucus Plugs in Asthma

Pulmonology
Explore the role of type 2 inflammation in the production of mucus plugs in asthma and the effects these plugs can have on patients.
View more
Role of Type 2 Cytokines in <b>Asthma</b> and COPD
expert video

Role of Type 2 Cytokines in Asthma and COPD

Type 2 Inflammation
Dr Mario Castro explains how type 2 cytokines play a crucial role in airway remodeling and inflammation in asthma and COPD, impacting patient outcomes.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With <b>Asthma</b>
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
Unraveling the Link of Type 2 Inflammation and Airway Remodeling in <b>Asthma</b>
expert video

Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma

Type 2 Inflammation
Join Dr. Celeste Porsbjerg as she discussed on how type 2 inflammation may lead to airway remodeling in asthma, exploring the pathophysiologic mechanisms, that ultimately lead to structural changes and irreversible loss of lung function
View more
Type 2 Inflammation Is a Significant Driver of Pediatric Severe <b>Asthma</b>
Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

Pulmonology
Learn about the role of type 2 inflammation in the burden and pathophysiology of severe asthma in pediatric patients
View more
Monitoring Lung Function Is an Important Aspect of Pediatric <b>Asthma</b> Management
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Pulmonology
Navigate through this interactive infographic to learn more about why lung function is important to monitor in pediatric patients with asthma and the noninvasive procedures that are available for implementation in clinical practice.
View more
Eosinophils as a Biomarker for Type 2 <b>Asthma</b>
expert video

Eosinophils as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.
View more
FeNO as a Biomarker for Type 2 <b>Asthma</b>
expert video

FeNO as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Eugene Bleecker presents the utility of FeNO as a biomarker of type 2 inflammation, and its role in the disease burden of asthma.
View more
GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric <b>Asthma</b> in Children 6-11 Years of Age
interactivity

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

Pulmonology
Explore GINA-based recommendations for identifying risk factors, optimizing management plans, and monitoring disease progression in pediatric asthma.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Costa RicaChange country/region